Literature DB >> 25456150

Genetic testing in persons with age-related macular degeneration and the use of the AREDS supplements: to test or not to test?

Emily Y Chew1, Michael L Klein2, Traci E Clemons3, Elvira Agrón4, Gonçalo R Abecasis5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25456150      PMCID： PMC4277900          DOI： 10.1016/j.ophtha.2014.10.012

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-10

2.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration.

Authors:  Michael L Klein; Peter J Francis; Bernard Rosner; Robyn Reynolds; Sara C Hamon; Dennis W Schultz; Jurg Ott; Johanna M Seddon
Journal:  Ophthalmology       Date:  2008-06       Impact factor: 12.079

3.  Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study.

Authors:  Carl C Awh; Steven Hawken; Brent W Zanke
Journal:  Ophthalmology       Date:  2014-09-04       Impact factor: 12.079

4.  No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.

Authors:  Emily Y Chew; Michael L Klein; Traci E Clemons; Elvira Agrón; Rinki Ratnapriya; Albert O Edwards; Lars G Fritsche; Anand Swaroop; Gonçalo R Abecasis
Journal:  Ophthalmology       Date:  2014-06-26       Impact factor: 12.079

5.  CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.

Authors:  Carl C Awh; Anne-Marie Lane; Steven Hawken; Brent Zanke; Ivana K Kim
Journal:  Ophthalmology       Date:  2013-08-21       Impact factor: 12.079
  5 in total
  20 in total

1.  Current Management of Age-Related Macular Degeneration.

Authors:  Cindy Ung; Ines Lains; Joan W Miller; Ivana K Kim
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 3.  Genetics and genetic testing for age-related macular degeneration.

Authors:  A Warwick; A Lotery
Journal:  Eye (Lond)       Date:  2017-11-10       Impact factor: 3.775

4.  No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.

Authors:  Freekje van Asten; Chi-Yang Chiu; Elvira Agrón; Traci E Clemons; Rinki Ratnapriya; Anand Swaroop; Michael L Klein; Ruzong Fan; Emily Y Chew
Journal:  Ophthalmology       Date:  2019-06-12       Impact factor: 12.079

5.  Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration: Independent Statistical Evaluations of Data from the Age-Related Eye Disease Study.

Authors:  Melissa J Assel; Fan Li; Ying Wang; Andrew S Allen; Keith A Baggerly; Andrew J Vickers
Journal:  Ophthalmology       Date:  2017-10-09       Impact factor: 12.079

6.  Five-year progression of unilateral age-related macular degeneration to bilateral involvement: the Three Continent AMD Consortium report.

Authors:  Nichole Joachim; Johanna Maria Colijn; Annette Kifley; Kristine E Lee; Gabriëlle H S Buitendijk; Barbara E K Klein; Chelsea E Myers; Stacy M Meuer; Ava G Tan; Elizabeth G Holliday; John Attia; Gerald Liew; Sudha K Iyengar; Paulus T V M de Jong; Albert Hofman; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Ronald Klein; Jie Jin Wang
Journal:  Br J Ophthalmol       Date:  2017-01-20       Impact factor: 4.638

Review 7.  Genetics of age-related macular degeneration (AMD).

Authors:  Margaret M DeAngelis; Leah A Owen; Margaux A Morrison; Denise J Morgan; Mingyao Li; Akbar Shakoor; Albert Vitale; Sudha Iyengar; Dwight Stambolian; Ivana K Kim; Lindsay A Farrer
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

8.  Reply.

Authors:  Freekje van Asten; Chi-Yang Chiu; Elvira Agrón; Traci E Clemons; Rinki Ratnapriya; Anand Swaroop; Michael L Klein; Ruzong Fan; Emily Y Chew
Journal:  Ophthalmology       Date:  2020-03       Impact factor: 12.079

9.  Vitamin A-aldehyde adducts: AMD risk and targeted therapeutics.

Authors:  Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-11       Impact factor: 11.205

Review 10.  The Age-Related Eye Disease 2 Study: Micronutrients in the Treatment of Macular Degeneration.

Authors:  Aruna Gorusupudi; Kelly Nelson; Paul S Bernstein
Journal:  Adv Nutr       Date:  2017-01-17       Impact factor: 8.701
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.